Literature DB >> 11493396

Community respiratory virus infections following lung transplantation.

J L Billings1, M I Hertz, C H Wendt.   

Abstract

Respiratory infections remain a significant cause of morbidity and mortality after lung transplantation. In addition to cytomegalovirus, the community respiratory viruses such as respiratory syncytial virus (RSV), parainfluenza virus (PIV), influenza virus, and adenovirus, are important causes of infection in transplant recipients, often involve the lower respiratory tract, and may be associated with significant morbidity and mortality. In this review, we summarize the current state of knowledge regarding the epidemiology, clinical manifestations, diagnosis, treatment and outcomes associated with RSV, PIV, influenza virus, and adenovirus infections in lung transplant recipients.

Entities:  

Mesh:

Year:  2001        PMID: 11493396     DOI: 10.1034/j.1399-3062.2001.003003138.x

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  15 in total

Review 1.  Real-time PCR in clinical microbiology: applications for routine laboratory testing.

Authors:  M J Espy; J R Uhl; L M Sloan; S P Buckwalter; M F Jones; E A Vetter; J D C Yao; N L Wengenack; J E Rosenblatt; F R Cockerill; T F Smith
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

Review 2.  Transplant-related immunosuppression: a review of immunosuppression and pulmonary infections.

Authors:  Michael D Duncan; David S Wilkes
Journal:  Proc Am Thorac Soc       Date:  2005

3.  Persistence of influenza vaccine-induced antibody in lung transplant patients and healthy individuals beyond the season.

Authors:  Jill J Severson; Katelyn R Richards; John J M Moran; Mary S Hayney
Journal:  Hum Vaccin Immunother       Date:  2012-08-21       Impact factor: 3.452

Review 4.  The host response and molecular pathogenesis associated with respiratory syncytial virus infection.

Authors:  Christine M Oshansky; Wenliang Zhang; Elizabeth Moore; Ralph A Tripp
Journal:  Future Microbiol       Date:  2009-04       Impact factor: 3.165

5.  Fatal adenovirus infection during alemtuzumab (anti-CD52 monoclonal antibody) treatment of a patient with fludarabine-refractory B-cell chronic lymphocytic leukemia.

Authors:  Nina Cavalli-Björkman; Eva Osby; Jeanette Lundin; Mats Kalin; Anders Osterborg; Astrid Gruber
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

6.  RNA interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy.

Authors:  Rene Alvarez; Sayda Elbashir; Todd Borland; Ivanka Toudjarska; Philipp Hadwiger; Mathias John; Ingo Roehl; Svetlana Shulga Morskaya; Rick Martinello; Jeffrey Kahn; Mark Van Ranst; Ralph A Tripp; John P DeVincenzo; Rajendra Pandey; Martin Maier; Lubomir Nechev; Muthiah Manoharan; Victor Kotelianski; Rachel Meyers
Journal:  Antimicrob Agents Chemother       Date:  2009-06-08       Impact factor: 5.191

7.  Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in France.

Authors:  P Loubet; N Lenzi; M Valette; V Foulongne; A Krivine; N Houhou; G Lagathu; S Rogez; S Alain; X Duval; F Galtier; D Postil; P Tattevin; P Vanhems; F Carrat; B Lina; O Launay
Journal:  Clin Microbiol Infect       Date:  2016-11-27       Impact factor: 8.067

8.  Using Home Spirometry for Follow up of Lung Transplant Recipients: "A Pilot Study".

Authors:  Lida Fadaizadeh; Katayoun Najafizadeh; Shadi Shafaghi; Mahsa Sadat Hosseini; Azadeh Ghoroghi
Journal:  Tanaffos       Date:  2013

9.  Detection of severe human metapneumovirus infection by real-time polymerase chain reaction and histopathological assessment.

Authors:  Kaharu C Sumino; Eugene Agapov; Richard A Pierce; Elbert P Trulock; John D Pfeifer; Jon H Ritter; Monique Gaudreault-Keener; Gregory A Storch; Michael J Holtzman
Journal:  J Infect Dis       Date:  2005-08-04       Impact factor: 5.226

10.  Viral Respiratory Tract Infection During the First Postoperative Year Is a Risk Factor for Chronic Rejection After Lung Transplantation.

Authors:  Jesper Magnusson; Johan Westin; Lars-Magnus Andersson; Magnus Lindh; Robin Brittain-Long; Rickard Nordén; Gerdt C Riise
Journal:  Transplant Direct       Date:  2018-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.